OneMedNet Reports Record Bookings as Faster Fulfillment Begins

OneMedNet reports sharply higher 2026 bookings and much faster data-fulfillment capability, supported by strong contribution from new and existing customers.

Rhea-AI Summary

OneMedNet (ONMD) reported approximately $16.2 million in year-to-date 2026 bookings, a 16X increase versus the same period in 2025.

Bookings include multi-modal datasets, datasets-plus-license arrangements, and multi-year platform access licenses, with a significant portion expected to be delivered during the remainder of 2026. Around 50% of 2026 contracts are from new customers, while existing customers are expanding through reorders and follow-on engagements. Platform enhancements have improved order-fulfillment speed by about 50X, enabling the company to handle larger orders and deliver faster.

Positive

• Year-to-date 2026 bookings approximately $16.2 million, up 16X vs. 2025 period
• Customer mix: about 50% of 2026 contracts from new customers
• Order fulfillment speed approximately 50X faster after platform improvements

Negative

• None.

News Explained

The release's year-to-date bookings remain a contracted-demand figure, with significant delivery expected later. Against $358,000 of cash at June 30, 2026, the announcement does not establish that bookings have already become cash.

Argus 15 min delay

+2.86% vs previous close $0.63 last price 102.5x rel. volume Open Argus

Details

Market Reaction – ONMD

+3.6% Peak in 0 min

$0.61 $0.67 Day Range

$37.53M Market Cap

Following this news, ONMD has gained 2.86%, reflecting a moderate positive market reaction. Argus tracked a peak move of +3.6% during the session. Our momentum scanner has triggered 5 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $0.63. Trading volume is exceptionally heavy at 102.5x the average, suggesting very strong buying interest.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

Comparable OneMedNet commercial announcements were followed by -7.15% on June 10 and 17.02% on July ...

Analysis

Comparable OneMedNet commercial announcements were followed by -7.15% on June 10 and 17.02% on July 28, showing mixed reactions to prior bookings and data-contract updates. This release reported another bookings milestone.

Key Figures

Year-to-date bookings: approximately $16.2 million Bookings growth: 16X increase New-customer contracts: approximately 50% +4 more

Year-to-date bookings

approximately $16.2 million

2026 year to date

Bookings growth

16X increase

versus the same period in 2025

New-customer contracts

approximately 50%

of contracts booked during 2026

Order-fulfillment speed

approximately 50X faster

following platform improvements

Healthcare partner sites

more than 2,300

OneMedNet network

Patient journeys

more than 90 million

OneMedNet network

Studies

270 million

OneMedNet network

Historical Context

2 past events · Latest: Jun 10

2 events

1. Jun 10

   Bookings update

   24h Move

   -7.2%

   Reported more than $3 million in new 2026 bookings, exceeding full-year 2025 bookings.

2. Jul 28

   Data agreement

   24h Move

   +17.0%

   Secured an agreement valued above $11.5 million for foundational AI model data.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

real-world data, multi-modal datasets, foundation-model development, cohort discovery

4 terms

real-world data medical

"a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data"

Real-world data consists of information collected from everyday sources outside of controlled experiments or official reports, such as patient records, insurance claims, or wearable device readings. For investors, it provides a more complete picture of how products and services perform in actual use, helping them make better-informed decisions based on how things work in real life rather than just in theory or controlled settings.

multi-modal datasets technical

"include a combination of fit-for-purpose multi-modal datasets"

Collections of related information that combine two or more types of data—such as numerical time series, text, images, audio, or tabular records—assembled for analysis or machine learning. Like a photo album that also includes recorded conversations and receipts for each picture, multi-modal datasets let algorithms relate different kinds of signals to one another; investors care because they fuel more comprehensive models and tools used for research, risk assessment, and automated decision systems.

foundation-model development technical

"for regulatory submissions, foundation-model development, cohort discovery"

Large-scale work to create base artificial intelligence models that are trained on vast amounts of text, images, code, or other data so they can be adapted for many different tasks. Like building a powerful engine that other products can plug into, foundation-model development involves architecture design, massive training runs, and safety or fine-tuning steps. It matters to investors because it drives a company’s technical capabilities, costs, potential product breadth, and intellectual-property or regulatory exposure.

cohort discovery medical

"foundation-model development, cohort discovery, feasibility studies"

Cohort discovery is the process of finding and defining a group of patients who meet specific medical or demographic criteria for a research study or clinical trial, typically by searching medical records, genetic data or other health information. For investors, effective cohort discovery speeds up patient recruitment, lowers trial costs and timelines, and improves the likelihood that a study will produce clear results—think of it as using a precise filter to find the right people in a crowd so a project can move forward efficiently.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Year-to-date bookings of $16.2 million include a combination of fit-for-purpose multi-modal datasets, datasets-plus-license arrangements, and multi-year platform access licenses; a significant portion of these bookings are expected to be delivered during the remainder of the year

MINNEAPOLIS, Sept. 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced year-to-date bookings of approximately $16.2 million, a 16X increase versus the same period in 2025. A significant portion of these bookings are expected to be delivered during the remainder of the year.

Approximately 50% of the contracts booked during 2026 are with new customers to OneMedNet, while the existing customer base continues to expand their business with the Company through high rates of reorder and follow-on engagement.

Platform improvements have increased OneMedNet’s order-fulfillment speed by approximately 50X, accelerating how quickly the Company can assemble, qualify, and deliver fit-for-purpose multi-modal datasets. This increase in speed allows the Company to take on large orders while providing quick delivery to meet our customers' project schedules.

Life sciences, medical device, and AI organizations continue to use OneMedNet’s iRWD™ Platform for regulatory submissions, foundation-model development, cohort discovery, feasibility studies, and high-value research, which is reflected in our bookings backlog. This builds on our network of more than 2,300 healthcare partner sites and more than 90 million patient journeys and 270 million studies.

Key Highlights

• Contracted demand: Approximately $16.2 million in year-to-date bookings, a 16X increase over the same period in 2025.
• Growth from new and existing customers: Approximately 50% of contracts booked during 2026 are with new customers to OneMedNet, complemented by reorder and expansion activity from existing customers.
• Faster fulfillment: Order fulfillment is approximately 50X faster, which allows the Company to take on larger orders and deliver faster.
  

“Our commercial engine is delivering,” said Aaron Green, CEO & President. “Bookings are up more than 16X year over year, and we are executing to our contracted delivery schedules. Expanding demand combined with disciplined execution is what builds durable value. The market is shifting decisively towards direct-from-source, regulatory grade Real-World Data, and OneMedNet through our provider network and advanced technology is positioned to deliver it at the speed, scale, and quality that modern healthcare innovation demands.”

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the potential of more than 2,300 healthcare sites through its iRWD™ platform. This is not just data — it is the foundation of innovation, from de-identified medical imaging to electronic health records, fueling work for drugmakers, medical device companies, and AI developers. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that support patient care and the next wave of healthcare innovation.

Learn more at www.onemednet.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to, statements regarding demand for our products and services, the composition and durability of our customer base, the speed of order fulfillment, the acceptance of our delivered data sets allowing for the conversion of bookings to revenue, our ability to achieve our operational strategies, our expected growth in the business, and statements generally about our products, plans and strategies.

Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include, but are not limited to: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What types of offerings are included in OneMedNet's 2026 bookings?

The 2026 bookings comprise a mix of fit-for-purpose multi-modal datasets, datasets-plus-license arrangements, and multi-year platform access licenses.

How are organizations using OneMedNet’s iRWD Platform?

Life sciences, medical device, and AI organizations use the iRWD Platform for regulatory submissions, foundation-model development, cohort discovery, feasibility studies, and other high-value research.

What is the scale of OneMedNet’s data and provider network?

The company reports a network of more than 2,300 healthcare partner sites, with access to over 90 million patient journeys and 270 million studies.